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Abstract
Background: Ovarian malignancies are important causes of morbidity and mortality and understanding 
their pathology go a long way in proffering adequate clinical management.  
Objective:  To determine the pattern, frequency and age distribution of malignant ovarian tumours 
received in the Pathology department of Aminu Kano Teaching Hospital, (AKTH), Kano over a 7 year 
period (2001  2007). 
Methods: A retrospective analysis of all malignant ovarian tumours received and processed at the 
Pathology Department of AKTH,  Kano between 1st January 2001 and 31st December 2007. 
Results: The ovarian tumours included 212 (66.2%) benign and 108 (33.8%) malignant cases. Serous 
cystadenocarcinoma was the most common malignant tumour representing 31.5% of all cases. Twenty 
eight cases of granulosa cell tumours accounting for 25.9% of the malignant tumours were next in 
frequency while dysgerminoma and Burkitt's lymphoma were the most common tumours seen in 
children in the first decade of life and constituted 5.5 and 2.8% of all malignant tumours respectively.
Conclusion: The study has shown that malignant tumours constitute about a third of all ovarian tumours seen 
in this North-Wesrtern part of Nigeria covered by Aminu Kano Teaching Hospital with serous 
cystadenocarcinoma being overall the most common malignant ovarian tumour and peak age range of 
occurrence being in the fifth decade. 
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Introduction Available literature has shown that tumours of 
Ovarian cancers are important causes of epithelial origin constitute 60-65%, germ cell 
morbidity and mortality in women and this tumours 15-20% and sex-cord stromal tumours 
15-10% among Caucasians.  The preponderance arises from observations that most produce non-
of epithelial malignancies in the developed specific symptomatology and in many cases 
countries is similar to the scenario in several would have reached advanced stages at the time 
4of diagnosis. countries in the West African sub-region.  
However, in Asians (including Indians and 
Epidemiologically, amongst cancers of the Japanese) and Ugandans, the incidence of 
female genital tract, malignant tumours of the malignant germ cell tumours in general is higher 
5ovary rank third after those of the endometrium than that seen in the west.  
1and cervix in the developed countries.  At 
present ovarian cancer is the sixth most common Several theories have been propounded to 
cancer and seventh most common cancer explain the aetiopathogenesis of ovarian 
related cause of death in women, with 204,000 cancers. First is the pelvic contamination theory 
new cases and 125,000 deaths worldwide in the which postulates that carcinogens, chemical or 
2
biological, that result in ovarian malignancies year 2005.  It however remains the most 
common cause of gynaecological related 
3deaths.  Developed countries report the highest 
incidence of the malignant tumours with rates in 
excess of 9 per 100,000 with the exception of 
Japan which has an incidence of 6.4 per 
2100,000.
gain entry to the pelvis through sanitary as age and laterality of the neoplasms were 
6products or surgical contamination.  The obtained from accompanying pathology request 
ovulation theory in the aetiopathogenesis of cards followed by retrieval of the Haematoxylin 
ovarian cancers has identified ovulation-related and Eosin stained slides which had been 
risk factors like low parity, early menarche, late produced from the biopsies of these cases. The 
7 slides were then reviewed and subsequently menopause and breast feeding.  This has been 
classified into  major histogenetic groups based hinged on the effect of uninterrupted cycles of 
on the 2002 World Health Organization ovulation resulting in continuous remodeling of 
International Classification of Diseases-the germinal epithelium with resultant tendency 
158 Oncology (WHO ICD-O) protocol.  The results towards metaplasia and dysplastic changes.  
were then analyzed using EPI INFO Database.Oral contraceptive pill use on the other hand has 
been shown to be protective against cancers of 
Resultsthe ovary for as long as 20 years after 
9 One hundred and eight cases of malignant discontinuation.  This may be due to their 
ovarian tumours were recorded during the study suppressive effect on follicle rupture and hence 
period and these represented 33.8% of all the decreased need for repeated repair of the 
ovarian tumours received. The ages ranged from ovarian surface epithelium
8 to 75 years with a mean of 38.8 ± 17.7years. 
As with most other tumours, advancing age is an 
Table 1 shows the age distribution of the various important risk factor, with risk increasing from 
histogenetic groups. Surface epithelial tumours 15.7 to 54 per 100,000 as age increases from 40 
8 accounted for 48 (44.5%) cases and sex-cord to 79 years.  The serous carcinomas are rare 
stromal tumours 30 (27.8%) cases. Twenty two before the second decade of life while mucinous 
10 cases of germ cell tumours were recorded carcinomas have a mean age of 53 to 54 years.  
representing 20.3% of the cases while Burkitt's Malignant ovarian germ cell tumours however 
lymphoma and metastatic tumours represented are most common in the first two decades of 
11 3 (2.8%) and 5(4.6%) cases respectively. life.  In more recent times the concept of 
Serous cystadenocarcinoma was the most Ovarian Intra-epithelial neoplasia (OIN) has been 
frequent malignant histological subtype gaining increasing consideration. This concept is 
representing 31.5% of all the malignant similar to the precursor lesions seen in the 
tumours, with a modal age range in the fifth vagina, cervix and prostate, and is based on the 
decade, but no statistically significant laterality. observation that in patients that have ovarian 
cancer, tissues adjacent to the cancer or from the 
These tumours were followed in frequency by contralateral ovary often show areas of cellular 
granulosa cell tumours, a subtype of sex-cord and / or nuclear atypia believed to represent 
12 stromal tumour, accounting for 25.9% of precursor lesions.  Other risk factors that have 
malignant tumours recorded. In general the also been identified for ovarian malignancies 
granulose cell tumours were largely uncommon include genetic factors, notable among which 
before the third decade while majority 80% (24 are the inheritable BRCA mutations and the 
13 cases) were seen from the fourth decade and Lynch 2 syndrome.  In terms of early diagnosis 
beyond. Malignant germ cell tumours were the three-Dimensional (3-D) imaging, using trans-
least common major histogenetic group with 22 vaginal probes is presently being used to study 
cases accounting for 20.3% of all the tumour angiogenesis and is anticipated to 
14 malignancies and showing a peak age frequency enable prediction of tumour behaviour.
in the second decade (10  19 years). The 
malignant germ cell tumour variant most Materials and Methods
commonly seen was the yolk sac tumour This retrospective study comprised all cases of 
(40.9%). Other uncommon types of malignant malignant ovarian tumours recorded in the 
t u m o u r s  s e e n  w e r e  t w o  c a s e s  o f  Histopathology Department of Aminu Kano 
st arrhenoblastoma, both in the fourth decade of Teaching hospital between 1  January, 2001 and 
st life, 3 cases of Burkitt's lymphoma (two in the 31 December, 2007. Relevant information such 
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first decade of life) and 5 metastatic tumours. to reports from sub-Saharan Africa which have 
indicated that malignant tumours represent 28 
25, 26Discussion to 33% of all ovarian tumours.  It also agrees 
 with findings of investigations in Kuala Lumpur,The true incidence of ovarian cancer in Africa is 
Malaysia where 31% of the reported cases of not known largely due to absence of population 
ovarian tumours were malignant and similar based Cancer Registries. However, available 
 with findings in Karachi (40.81%) and other literature suggest that the incidence is relatively 
27-29low compared to those in Northern and Eastern studies from Europe and America.
Europe and the Middle East where comparative 
studies among Negroid and Caucasian races Recent studies have indicated a steady rise in the 
15-17
incidence of malignant surface epithelial have been carried out.
tumours in areas with previously low rates even 
though not to the levels seen in North Americans The proportion of malignant ovarian tumours 
30, 31relative to all malignant gynaecological tumours and Europeans.  A 25-year review of ovarian 
 has been documented to show variation in cancers in Osaka, Japan, showed an increase in 
various regions of Nigeria. In Sokoto it was the incidence of carcinomas, particularly the 
18.2%, Maiduguri 16.3%, Lagos 14.1%, Ibadan serous and mucinous varieties, with the 
 9.8%, Zaria 8.9% but as high as 24.1% in this incidence of germ cell tumours remaining stable, 
18-22
while that for sex-cord stromal tumours showed study. Among female in developed countries 
30 16 a decline.  While a multi-centre study is required frequency rates of about 30% are reported.  
to evaluate the trend in Nigeria, a three and a 
half-year longitudinal study by Odukogbe et al The observed proportion of 33.8% of malignant 
reported that tumours of epithelial origin  ovarian tumours relative to all ovarian tumours 
constituted as high as 76.2% of  all the malignant in this study  is greater than findings from Benin 
 
ovarian tumours seen at the University College City and Maiduguri, Nigeria where 19% and 
2120.7% respectively of ovarian tumours were Hospital, Ibadan, Nigeria.  The authors 
23, 24
suggested declining fertility and increasing use reported to be malignant.  It is however closer 
37, 38also been adduced for this.of ovulation inducing drugs as likely responsible 
factors for these changes. This is corroborated by 
Malignant sex-cord stromal tumours were next the findings of a British study which showed that 
in frequency to the surface epithelial tumours in age specific incidence rates have remained 
this study constituting 27.8% of the cases seen.  stable in the younger population, while 
This is comparable with findings in South Africa increasing among the older population above 65 
 26, 3932 (22.9%) and India (21.4%).  The malignant sex years of age. The disparity was also attributed 
cord stromal tumours were predominantly to the widespread use of contraceptive pills in 
represented by granulosa cell tumours, the younger generation, thus contributing to 
accounting for 25.9% of all the ovarian tumours their relative protection from ovarian 
in this study and in concordance with other carcinomas. 
22, 23, 25, 39studies in Nigeria, Africa and Asia. Adult 
Findings from the present study show serous granulosa cell tumours were the more common 
cystadenocarcinoma to be the most common variety and the majority, 14 (50%) of cases, 
malignant ovarian tumour, accounting for 31.5% occurred between 30-59 years. This age 
of all the malignant cases seen. This is distribution is about a decade earlier than that 
comparable to findings in Zaria, Nigeria (23.9%), reported by an Israeli study (age range 40-59 
22, 33 
years) which also showed a higher incidence of and Karachi, Pakistan (33.3%).   It contrasts 
these tumours amongst women of European and however with a study by Okonofua et al in Ile-Ife, 
American origin compared to those of African Nigeria where of 31 consecutive cases of ovarian 
40c a r c i n o m a s  t h e y  f o u n d  m u c i n o u s  and Asian descent.  
cystadenocarcinoma (52% of cases) to be the 
34
Malignant germ cell tumours were the least most common epithelial malignancy. 
frequent histogenetic group and constituted The serous and mucinous cystadenocarcinomas 
6.9% of all ovarian neoplasms seen over the were predominantly seen in women in the fifth 
study period. This is  consistent with decade of life which concurs with observations 
observations in the literature that have on the predilection of these epithelial tumours 
1   for older age groups. However while the documented the incidence to be about 35%. 
Surveilance Epidemiology and End Results             The endemicity of Burkitt's lymphoma in Africa 
35
has long been established but worldwide the (SEERS) cancer statistics review  has revealed 
41that only about 13% of ovarian cancer bearing incidence has varied.    The rarity of adult 
women are 45 years or younger this study shows ovarian Burkitt's lymphoma is supported by the 
that 43.5% of the cases are younger than 40 finding of only 10 cases over a 27-year period in a 
years. Similarly Kyari et al in Maiduguri also review by Konje et al in Ibadan, representing a 
42documented that 23% of cases were below 40 frequency of only 1.3%.  In this study two out of 
19years of age.  A comparative population based the three cases of ovarian Burkitt's lymphoma 
study in Israel reported that not only did the seen were bilateral. All three cases were below 
Afro-Asian immigrants have a lower incidence the age of 20 years with a mean age of about ten 
rate for epithelial cancers, the peak age at years, a finding comparable to reports from 
diagnosis was about a decade earlier than those Zaria, Northern Nigeria, where the only case 
36  22of European and North American descent.    In documented was below the age of ten years.
addition while the reported median age in the 
SEERS data is 63 years, it was 49 years in this Three (75%) of the 5 metastatic tumours to the 
study. The lower average life expectancy in ovaries seen in this study were well 
developing countries has been suggested for this differentiated adenocarcinomas that were 
37
established clinically to be of gastrointestinal variance,  thus the women may not live long into 
tract origin. This is consistent with findings by the age range where these tumours are more 
Yada-Hashimoto et al in a Japanese study frequently seen as among Caucasians. Other 
reporting non-gynaecological primaries (59.3%) suggestions for this difference include possible 
 to be more common in their series of 64 women.genetic differences in metabolism of female sex 
4 3hormones, and higher parity among Africans has  V a r i o u s  h i s t o c h e m i c a l  a n d  
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immunohistochemical stains are employable to all ovarian tumours, were predominantly serous 
differentiate primary and secondary ovarian cystadenocarcinomas and  have peak age range 
tumours from one another. For example positive of occurrence in the fifth decade similar to most 
mucicarmine, PAS with diastase and cytokeratin African and Asian studies but earlier than 
7 and 20 help in diagnosing the Krukenberg observed from Caucasian populations.
15tumours.  We were however constrained by the T h e re  i s  n e ed  fo r  est a b l i s h m e nt  o f  
by the absence of such facilities at out centre to immunohistochemical techniques in hospital 
e n a b l e  m o r e  a c c u r a t e  h i s t o l o g i c a l  laboratories and up to date radiological 
categorization. equipment to facilitate prompt and reliable 
diagnosis. This is second only to the need to 
In conclusion this 7-year histopathological establish local and national Cancer Registries to 
review of malignant ovarian tumours in AKTH enable comprehensive epidemiological data 
has shown that they constitute about a third of collection.     
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